Avesthagen sails into Latin American waters. Forms Avesthagen Latam SpA to tap a large emerging market for its technologies, products and services. Announces strategic alliance with Chilean biotech company - Uxmal S.A.  The venture is being actively supported by the Chilean government.

It’s March Madness Monday, and brackets are sweeping America. Meanwhile, Pharma is in the midst of a big-money, single-elimination tourney of its own: M&A.

Is rural India a new promised land for drugmakers? Several multinational pharma companies are targeting the subcontinent's countryside for expansion, local media reports. It's part of pharma's new focus on emerging markets but with a twist.

Japan's drugmakers will sit out a wave of consolidation sweeping through the industry, focusing instead on integrating past acquisitions and smaller, bolt-on deals.